PEPTIDES AND DIABETES TREATMENT METHODS Russian patent published in 2021 - IPC C07K14/62 C07K7/08 A61K39/00 A61P3/10 

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology, specifically to immunogen peptides; it can be used in medicine for the treatment of type 1 diabetes. Immunogen peptide is proposed with a length from 17 to 50 amino acids, containing a sequence CXX[CST]SLQPLALEGSLQK or [CST]XXCSLQPLALEGSLQK, where X is amino acid, and where [CST] is one of C, S or T.

EFFECT: invention provides for obtaining cytolytic CD4+T-cells that are characterized in increased production of IFN-gamma and sFasL compared to peptides of current technology state.

11 cl, 2 dwg, 2 tbl, 6 ex